Expertise in
26
conditions

Andrea Biondi

Milan, IT 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
26
conditions
Milan, IT 

Overview

Andrea Biondi practices practicing medicine in Milan, Italy.

Ms. Biondi is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Rubinstein-Taybi Syndrome, Bone Marrow Transplant, and Osteotomy.

She is actively involved in clinical research, co-authoring 445 peer reviewed articles and participating in 5 clinical trials.

Gender

Female

Locations

Milan, Italy
Other Locations
Monza, Italy
San Gerardo, Italy
Bologna, Italy
IRCCS Policlinico San Donato
San Donato Di Ninea, Italy
Pavia, Italy
Tor Vergata Via Montpellier 1, Rome, 00133, Italy
San Donato Milanese, Italy
Trieste, 34100, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

INTERNATIONAL STUDY of Chronic Myeloid Leukaemia (CML) Treatment and Outcomes in Children and Adolescents
INTERNATIONAL STUDY of Chronic Myeloid Leukaemia (CML) Treatment and Outcomes in Children and Adolescents
Enrollment Status: Recruiting
Publish Date: January 17, 2024
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Enrollment Status: Active_not_recruiting
Publish Date: August 19, 2026
Intervention Type: Drug, Procedure, Other, Biological
Study Drugs: Cyclophosphamide, Cytarabine, Daunorubicin Hydrochloride, Dexamethasone, Dexrazoxane Hydrochloride, Doxorubicin, Etoposide, Filgrastim, Ifosfamide, Imatinib Mesylate, Leucovorin Calcium, Mercaptopurine, Methotrexate, Methylprednisolone, Pegaspargase, Prednisolone, Hydrocortisone, Thioguanine, Vincristine Sulfate
Study Phase: Phase 3
Dose Escalating Study to Evaluate Pharmacokinetics, Efficacy and Safety of Apotransferrin in Atransferrinemia Patients
Dose Escalating Study to Evaluate Pharmacokinetics, Efficacy and Safety of Apotransferrin in Atransferrinemia Patients
Enrollment Status: Active_not_recruiting
Publish Date: August 03, 2025
Intervention Type: Drug
Study Drug: Apotransferrin
Study Phase: Phase 2
Phase 1-2a Trial to Determine the Feasibility and Safety of a Single Dose of Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Adult and Pediatric Patients With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia, After Hematopoietic Stem Cell Transplantation
Phase 1-2a Trial to Determine the Feasibility and Safety of a Single Dose of Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Adult and Pediatric Patients With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia, After Hematopoietic Stem Cell Transplantation
Enrollment Status: Completed
Publish Date: May 06, 2023
Intervention Type: Biological
Study Drug: CD19-Positive CAR-T Cells
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

445 Total Publications

CAR T-Cell Therapy in Acute Lymphoblastic Leukemia-Is Limited Persistence Enough?
CAR T-Cell Therapy in Acute Lymphoblastic Leukemia-Is Limited Persistence Enough?
Journal: JAMA oncology
Published: September 03, 2026

Frequently Asked Questions about Andrea Biondi

Is Andrea Biondi a top-rated expert for Acute Lymphoblastic Leukemia (ALL)?

MediFind is an objective health platform that identifies experts based on real-world data. Andrea Biondi is classified as an Distinguished expert for Acute Lymphoblastic Leukemia (ALL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Andrea Biondi participate in research or clinical trials?

Yes. Andrea Biondi has published 445 articles and abstracts on conditions like Acute Lymphoblastic Leukemia (ALL). You can view a list of Andrea Biondi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Biondi's expertise for a condition
ConditionClose
    View All 22 Advanced Conditions
    View All 83 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile